Gerold Schuler

Q: What Schools Are Affiliated With Gerold Schuler

Gerold Schuler is affiliated with the following schools: University of Innsbruck, Université catholique de Louvain, University of Erlangen–Nuremberg, ETH Zurich, Rockefeller University, University of Basel, University of Würzburg, Kyoto University, University of Zurich

Gerold Schuler's AcademicInfluence.com Rankings

Gerold Schuler

Computer Science

#4132

World Rank

#4348

Historical Rank

Computational Linguistics

#338

World Rank

#343

Historical Rank

Machine Learning

#718

World Rank

#728

Historical Rank

Artificial Intelligence

#920

World Rank

#937

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Gerold Schuler's Degrees

PhD Computer Science ETH Zurich
Masters Computer Science University of Zurich
Bachelors Computer Science University of Zurich

Similar Degrees You Can Earn

Why Is Gerold Schuler Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gerold Schuler's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. (1999) (3146)
Proliferating dendritic cell progenitors in human blood (1994) (2071)
Induction of Interleukin 10–Producing, Nonproliferating Cd4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells (2000) (1723)
Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? (2002) (1451)
Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma (1999) (1320)
Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood (2001) (1274)
Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro (1985) (1144)
High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 [published erratum appears in J Exp Med 1996 Oct 1;184(4):following 1590] (1996) (1068)
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. (1996) (867)
Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. (1996) (751)
Interleukin‐12 is produced by dendritic cells and mediates T helper 1 development as well as interferon‐γ production by T helper 1 cells (1996) (741)
Repetitive Injections of Dendritic Cells Matured with Tumor Necrosis Factor α Induce Antigen-specific Protection of Mice from Autoimmunity (2002) (632)
Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells (1988) (557)
Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1 (1994) (546)
Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. (1999) (544)
Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. (1999) (534)
Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy. (2016) (528)
Immature dendritic cells generated with low doses of GM‐CSF in the absence of IL‐4 are maturation resistant and prolong allograft survival in vivo (2000) (527)
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. (1996) (524)
Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells (1987) (523)
Human CD4+CD25+ Regulatory, Contact-dependent T Cells Induce Interleukin 10–producing, Contact-independent Type 1-like Regulatory T Cells (2002) (512)
Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells (2002) (504)
Identification of proliferating dendritic cell precursors in mouse blood (1992) (489)
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. (2016) (467)
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. (2006) (457)
Ultraviolet light depletes surface markers of Langerhans cells. (1981) (455)
Dendritic Cells as Vectors for Therapy (2001) (430)
The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network (2013) (411)
Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. (1989) (401)
A comparison of two types of dendritic cell as adjuvants for the induction of melanoma‐specific T‐cell responses in humans following intranodal injection (2001) (396)
Mature Dendritic Cells Infected with Herpes Simplex Virus Type 1 Exhibit Inhibited T-Cell Stimulatory Capacity (2000) (313)
Matrix Metalloproteinases 9 and 2 Are Necessary for the Migration of Langerhans Cells and Dermal Dendritic Cells from Human and Murine Skin1 (2002) (308)
Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells. (2009) (307)
Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. (1993) (298)
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo (2012) (293)
Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. (1993) (243)
Cutaneous Na+ storage strengthens the antimicrobial barrier function of the skin and boosts macrophage-driven host defense. (2015) (235)
Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes (1986) (225)
Mage-3 and Influenza-Matrix Peptide-Specific Cytotoxic T Cells Are Inducible in Terminal Stage HLA-A2.1+ Melanoma Patients by Mature Monocyte-Derived Dendritic Cells1 (2000) (225)
Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation (1990) (225)
The use of dendritic cells in cancer immunotherapy. (2003) (221)
Expression of Thy-1 antigen by murine epidermal cells. (1983) (215)
The Extracellular Domain of CD83 Inhibits Dendritic Cell–mediated T Cell Stimulation and Binds to a Ligand on Dendritic Cells (2001) (210)
Interleukin 7 is produced by murine and human keratinocytes (1993) (204)
Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in the mechanobullous diseases. (1981) (191)
Isolation of Dendritic Cells (1998) (190)
Topical imiquimod treatment of a cutaneous melanoma metastasis. (2000) (184)
Infliximab in the treatment of moderate to severe atopic dermatitis. (2005) (181)
Artesunate in the treatment of metastatic uveal melanoma--first experiences. (2005) (179)
Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain. (2002) (176)
Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells (1990) (175)
Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto‐nucleotidases (1999) (175)
A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use. (2000) (170)
Cytokine gene expression in murine epidermal cell suspensions: interleukin 1 beta and macrophage inflammatory protein 1 alpha are selectively expressed in Langerhans cells but are differentially regulated in culture (1992) (160)
Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. (1991) (159)
Inhibition of Cd83 Cell Surface Expression during Dendritic Cell Maturation by Interference with Nuclear Export of Cd83 mRNA (2000) (159)
IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. (1995) (156)
Type I Regulatory T Cells Specific for Desmoglein 3 Are More Frequently Detected in Healthy Individuals than in Patients with Pemphigus Vulgaris1 (2004) (154)
Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors. (2019) (151)
Differential Functions of IL-4 Receptor Types I and II for Dendritic Cell Maturation and IL-12 Production and Their Dependency on GM-CSF1 (2002) (151)
Treatment of psoriatic arthritis with antitumour necrosis factor‐α antibody clears skin lesions of psoriasis resistant to treatment with methotrexate (2001) (149)
Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes (2000) (144)
Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories. (2002) (138)
Culture of bone marrow cells in GM‐CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen‐ specific CD4 T cell anergy in vitro (2000) (137)
Dendritic cells: multi-lineal and multi-functional. (2000) (131)
Human cutaneous dendritic cells migrate through dermal lymphatic vessels in a skin organ culture model. (1996) (129)
Entry into afferent lymphatics and maturation in situ of migrating murine cutaneous dendritic cells. (1998) (128)
Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. (2007) (128)
The Thy-1-bearing cell of murine epidermis. A distinctive leukocyte perhaps related to natural killer cells (1985) (126)
Migration of Langerhans cells and dermal dendritic cells in skin organ cultures: augmentation by TNF‐α and IL‐1 β (1999) (124)
Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation. (2010) (119)
Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo (2015) (118)
Consensus nomenclature for CD8+ T cell phenotypes in cancer (2015) (118)
Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment (2016) (117)
BP230- and BP180-specific auto-antibodies in bullous pemphigoid. (2004) (113)
Signaling Lymphocytic Activation Molecule Is Expressed on Mature CD83+ Dendritic Cells and Is Up-Regulated by IL-1β1 (2001) (109)
IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses. (1988) (109)
A strikingly constant ratio exists between Langerhans cells and other epidermal cells in human skin. A stereologic study using the optical disector method and the confocal laser scanning microscope. (2001) (109)
Dendritic Cells Matured With TNF can be Further Activated In Vitro and After Subcutaneous Injection In Vivo Which Converts Their Tolerogenicity Into Immunogenicity (2006) (109)
REJECTION, AFTER A SLIGHTLY PROLONGED SURVIVAL TIME, OF LANGERHANS CELL‐FREE ALLOGENEIC CULTURED EPIDERMIS USED FOR WOUND COVERAGE IN HUMANS (1988) (109)
Dichotomy of Autoreactive Th1 and Th2 Cell Responses to Desmoglein 3 in Patients with Pemphigus Vulgaris (PV) and Healthy Carriers of PV-Associated HLA Class II Alleles1 (2003) (106)
Polyclonal CTL Responses Observed in Melanoma Patients Vaccinated with Dendritic Cells Pulsed with a MAGE-3.A1 Peptide 1 (2003) (104)
Efficient elutriation of monocytes within a closed system (Elutra) for clinical-scale generation of dendritic cells. (2005) (103)
Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy. (2017) (103)
Autoreactive T and B Cells from Bullous Pemphigoid (BP) Patients Recognize Epitopes Clustered in Distinct Regions of BP180 and BP2301 (2006) (102)
Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer (2009) (102)
Generation of an Optimized Polyvalent Monocyte-Derived Dendritic Cell Vaccine by Transfecting Defined RNAs after Rather Than before Maturation1 (2005) (102)
Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the philadelphia translocation and can induce a CML‐specific primary cytotoxic T‐cell response (1997) (100)
Short German guidelines: Malignant melanoma (2008) (99)
In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice (2006) (98)
Expression of basement membrane zone antigens at the dermo-epibolic junction in organ cultures of human skin. (1980) (98)
A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes (2006) (96)
Mutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations (2013) (94)
HIV Nef, paxillin, and Pak1/2 regulate activation and secretion of TACE/ADAM10 proteases. (2013) (93)
Intravenous immunoglobulin treatment in therapy-resistant epidermolysis bullosa acquisita. (1997) (92)
Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents (2010) (91)
The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells. (2009) (91)
Infliximab (anti-tumor necrosis factor alpha antibody): a novel, highly effective treatment of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease). (2001) (91)
Leg ulcers associated with long-term hydroxyurea therapy. (1998) (90)
"Intravascular lymphomatosis" (angioendotheliomatosis): evidence for a T-cell origin in two cases. (1990) (90)
Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma. (2008) (89)
Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice (2013) (88)
Cloning, recombinant expression and biochemical characterization of the murine CD83 molecule which is specifically upregulated during dendritic cell maturation (1999) (88)
Combination chemotherapy with or without s.c. IL-2 and IFN-α: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM) (2002) (87)
HIV-1 Nef mimics an integrin receptor signal that recruits the polycomb group protein Eed to the plasma membrane. (2004) (86)
Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation. (2004) (86)
A comparison of murine epidermal Langerhans cells with spleen dendritic cells. (1985) (85)
Understanding the dendritic cell lineage through a study of cytokine receptors (1994) (84)
Rapid control of therapy‐refractory pemphigus vulgaris by treatment with the tumour necrosis factor‐α inhibitor infliximab (2005) (80)
TCR-Like Human Antibodies Expressed on Human CTLs Mediate Antibody Affinity-Dependent Cytolytic Activity1 (2002) (80)
Antigen loading of dendritic cells with whole tumor cell preparations. (2003) (79)
Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patients. (2015) (78)
Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial. (2010) (78)
An improved isolation method for murine migratory cutaneous dendritic cells. (1996) (77)
Rapid improvement of recalcitrant disseminated granuloma annulare upon treatment with the tumour necrosis factor‐α inhibitor, infliximab (2005) (75)
HIV-Nef and ADAM17-Containing Plasma Extracellular Vesicles Induce and Correlate with Immune Pathogenesis in Chronic HIV Infection (2016) (75)
Dendritic cells: from ignored cells to major players in T-cell-mediated immunity. (1997) (74)
Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients (2018) (74)
Functional Analysis of Tumor-Specific Th Cell Responses Detected in Melanoma Patients after Dendritic Cell-Based Immunotherapy1 (2004) (73)
Epidermal Langerhans Cells (1990) (73)
Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan‐linked polyvinylalcohol adsorber (2003) (73)
The highly attenuated vaccinia virus strain modified virus Ankara induces apoptosis in melanoma cells and allows bystander dendritic cells to generate a potent anti‐tumoral immunity (2006) (70)
Ontogeny of Ia-positive and Thy-1-positive leukocytes of murine epidermis. (1986) (70)
RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma (2017) (70)
Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting. (2008) (69)
Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients. (2017) (68)
Dendritic cells in cancer immunotherapy (2010) (67)
Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA. (2005) (66)
Formation and kinetics of MHC class I-ovalbumin peptide complexes on immature and mature murine dendritic cells. (2000) (65)
A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr) (2005) (65)
Functions of Anti-MAGE T-cells induced in melanoma patients under different vaccination modalities. (2008) (64)
Expression of maturation-/migration-related molecules on human dendritic cells from blood and skin. (1998) (64)
Human large granular lymphocytes and their relationship to natural killer cell activity in various disease states. (1984) (62)
Immediate pigment darkening phenomenon. A reevaluation of its mechanisms. (1986) (61)
Anti-TNF-refractory colitis after checkpoint inhibitor therapy: Possible role of CMV-mediated immunopathogenesis (2016) (60)
Prolonged Clinical Remission of Patients with Severe Pemphigus upon Rapid Removal of Desmoglein-Reactive Autoantibodies by Immunoadsorption (2006) (60)
Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation. (2001) (59)
Inhibition of the Transcription Factor Foxp3 Converts Desmoglein 3-Specific Type 1 Regulatory T Cells into Th2-Like Cells1 (2006) (58)
Effective Clinical-scale Production of Dendritic Cell Vaccines by Monocyte Elutriation Directly in Medium, Subsequent Culture in Bags and Final Antigen Loading Using Peptides or RNA Transfection (2007) (58)
Topical imiquimod as treatment for different kinds of cutaneous lymphoma. (2006) (57)
The immunologic properties of epidermal Langerhans cells as a part of the dendritic cell system (2004) (56)
Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation (2005) (54)
GM-CSF Monocyte-Derived Cells and Langerhans Cells As Part of the Dendritic Cell Family (2017) (54)
Antigen processing in populations of mature murine dendritic cells is caused by subsets of incompletely matured cells. (1995) (54)
Life-threatening Autoimmune Cardiomyopathy Reproducibly Induced in a Patient by Checkpoint Inhibitor Therapy. (2018) (54)
Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg. (2013) (53)
Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients (2015) (52)
Autoimmune Colitis and Subsequent CMV-induced Hepatitis After Treatment With Ipilimumab. (2015) (52)
Mature monocyte‐derived dendritic cells respond more strongly to CCL19 than to CXCL12: consequences for directional migration (2006) (51)
MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patients. (2018) (51)
Still Alive and Kicking: In-Vitro-Generated GM-CSF Dendritic Cells! (2016) (50)
Primary leptomeningeal melanoma. Diagnosis by ultrastructural cytology of cerebrospinal fluid and cranial computed tomography (1982) (50)
Dendritic cells and apoptosis in mycosis fungoides (2002) (49)
MAGE-A3 is a frequent tumor antigen of metastasized melanoma (2004) (49)
Efficient expression of the tumor-associated antigen MAGE-3 in human dendritic cells, using an avian influenza virus vector. (2000) (49)
A natural variability in the proline-rich motif of Nef modulates HIV-1 replication in primary T cells (2001) (48)
A polyclonal anti‐vaccine CD4 T cell response detected with HLA‐DP4 multimers in a melanoma patient vaccinated with MAGE‐3.DP4‐peptide‐pulsed dendritic cells (2005) (47)
Cloning and characterization of the promoter region of the human CD83 gene. (2002) (45)
Hemopoietic stem cell inhibitor (SCI/MIP-1 alpha) also inhibits clonogenic epidermal keratinocyte proliferation. (1993) (45)
Granulocyte‐macrophage colony‐stimulating factor induces a unique set of STAT factors in murine dendritic cells (1997) (45)
The siRNA‐mediated downregulation of PD‐1 alone or simultaneously with CTLA‐4 shows enhanced in vitro CAR‐T‐cell functionality for further clinical development towards the potential use in immunotherapy of melanoma (2018) (44)
Nonviral RNA transfection to transiently modify T cells with chimeric antigen receptors for adoptive therapy. (2013) (44)
Junctional blisters in acquired bullous disorders of the dermal‐epidermal junction zone: role of the lamina lucida as the mechanical locus minoris resistentiae * (1983) (44)
Sneddon's Syndrome—An Inflammatory Disorder of Small Arteries Followed by Smooth Muscle Proliferation: Immunohistochemical and Ultrastructural Evidence (1995) (43)
Microscopic and fine structural aspects of porphyrias. (1982) (43)
Melanoma or not? Cancer testis antigens may help (2004) (42)
The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma (2018) (41)
Successful treatment of calciphylaxis with pamidronate. (2008) (41)
C-reactive protein as an early marker of immune-related adverse events (2019) (41)
Leukocyte Infiltration and mRNA Expression of IL-20, IL-8 and TNF-R p60 in Psoriatic Skin is Driven by TNF-α (2006) (39)
Circulation and homing of melanoma‐reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte‐derived dendritic cells (2004) (39)
Successful treatment of therapy‐resistant chronic vegetating pyoderma gangrenosum with infliximab (chimeric antitumour necrosis factor antibody) (2004) (39)
A GMP-compliant protocol to expand and transfect cancer patient T cells with mRNA encoding a tumor-specific chimeric antigen receptor (2014) (39)
Generation of Human Dendritic Cells That Simultaneously Secrete IL-12 and Have Migratory Capacity by Adenoviral Gene Transfer of hCD40L in Combination With IFN-γ (2009) (38)
Association of gene expression profile in metastatic melanoma and survival to a dendritic cell-based vaccine. (2009) (37)
Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance (2019) (37)
Anti-cytotoxic T-cell lymphocyte antigen-4-induced regression of spinal cord metastases in association with renal failure, atypical pneumonia, vision loss, and hearing loss. (2012) (37)
HIV Nef- and Notch1-dependent Endocytosis of ADAM17 Induces Vesicular TNF Secretion in Chronic HIV Infection (2016) (37)
Concurrent interaction of DCs with CD4+ and CD8+ T cells improves secondary CTL expansion: It takes three to tango (2014) (36)
Malignant Melanoma of the Skin: Long-term Follow-up and Time to First Recurrence (2011) (36)
Delayed response of oral pemphigus vulgaris to rituximab treatment. (2006) (36)
Activated CD4+ CD25+ T cells suppress antigen‐specific CD4+ and CD8+ T cells but induce a suppressive phenotype only in CD4+ T cells (2005) (36)
Cutting Edge: Resistance to Apoptosis and Continuous Proliferation of Dendritic Cells Deficient for TNF Receptor-11 (2000) (35)
Histiocytosis X cells in eosinophilic granuloma express Ia and T6 antigens. (1983) (35)
Vaccinia virus impairs directional migration and chemokine receptor switch of human dendritic cells (2007) (34)
Combined low-dose ipilimumab and pembrolizumab after sequential ipilimumab and pembrolizumab failure in advanced melanoma. (2016) (33)
Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes (2008) (33)
Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients (2018) (33)
Effective enrichment of murine epidermal Langerhans cells by a modified(mismatched) panning technique. (1992) (32)
Prevention of cutaneous melanoma: an epidemiological evaluation of the Swiss campaign. (1992) (32)
Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone (2015) (31)
RNA-stabilized whole blood samples but not peripheral blood mononuclear cells can be stored for prolonged time periods prior to transcriptome analysis. (2011) (31)
Structural and functional relationships between epidermal Langerhans cells and dendritic cells. (1989) (30)
Kurzleitlinie – Malignes Melanom der Haut (2006) (29)
Enrichment of epidermal Langerhans cells by immunoadsorption to Staphylococcus aureus cells. (1983) (29)
Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells—An Update (2020) (29)
Ex vivo analysis of desmoglein 1‐responsive T‐helper (Th) 1 and Th2 cells in patients with pemphigus foliaceus and healthy individuals (2005) (29)
Dendritic cell production of cytokines and responses to cytokines. (1990) (28)
DC-ATLAS: a systems biology resource to dissect receptor specific signal transduction in dendritic cells (2010) (28)
Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients (2018) (28)
Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patients. (2015) (28)
Psoriasis confined strictly to vitiligo areas – a Koebner‐like phenomenon? (2006) (27)
[Brief guidelines: malignant melanoma of the skin]. (2006) (27)
Isolation of Dendritic Cells (1998) (27)
Cryopreservation impairs 3-D migration and cytotoxicity of natural killer cells (2020) (26)
Senescence markers: Predictive for response to checkpoint inhibitors (2018) (26)
Combining a chimeric antigen receptor and a conventional T‐cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi‐hit immunotherapy of melanoma (2016) (26)
Morphological and phenotypical characterization of bone marrow-derived dendritic Thy-1-positive epidermal cells of the mouse. (1985) (24)
Pivotal Advance: Heme oxygenase 1 expression by human CD4+ T cells is not sufficient for their development of immunoregulatory capacity (2010) (24)
A fast and robust method to clone and functionally validate T-cell receptors. (2009) (24)
Late syphilis mimicking a pseudolymphoma of the skin. (2006) (24)
Triggering of NF‐κB in cytokine‐matured human DCs generates superior DCs for T‐cell priming in cancer immunotherapy (2014) (23)
Interdependency of MHC Class II/Self-Peptide and CD1d/Self-Glycolipid Presentation by TNF-Matured Dendritic Cells for Protection from Autoimmunity1 (2007) (23)
Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma Registry. (2017) (23)
Differences in phenotype and function between spontaneously occurring melan‐A‐, tyrosinase‐ and influenza matrix peptide‐specific CTL in HLA‐A*0201 melanoma patients (2005) (22)
Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis (2017) (22)
Tumor-Reactive CD4+ T Cell Responses to the Melanoma-Associated Chondroitin Sulphate Proteoglycan in Melanoma Patients and Healthy Individuals in the Absence of Autoimmunity1 (2007) (21)
[Immunotherapy of uveal melanoma: vaccination against cancer. Multicenter adjuvant phase 3 vaccination study using dendritic cells laden with tumor RNA for large newly diagnosed uveal melanoma]. (2015) (21)
Treatment of inflammatory dermatoses by tumour necrosis factor antagonists (2006) (21)
Human Adenovirus-Specific γ/δ and CD8+ T Cells Generated by T-Cell Receptor Transfection to Treat Adenovirus Infection after Allogeneic Stem Cell Transplantation (2014) (21)
Murine epidermal Langerhans cells as a model to study tissue dendritic cells. (1993) (21)
Production and properties of large numbers of dendritic cells from human blood. (1995) (21)
M1204, a novel 2',5' oligoadenylate synthetase with a ubiquitin-like extension, is induced during maturation of murine dendritic cells. (1999) (21)
Effective anti‐programmed death‐1 therapy in a SUFU‐mutated patient with Gorlin–Goltz syndrome (2018) (21)
Third-Kind Encounters in Biomedicine: Immunology Meets Mathematics and Informatics to Become Quantitative and Predictive. (2016) (20)
Multiepitope tissue analysis reveals SPPL3-mediated ADAM10 activation as a key step in the transformation of melanocytes (2017) (20)
Dendritic cell-T cell conjugates that migrate from normal human skin are an explosive site of infection for HIV-1. (1995) (20)
Optimizing the exogenous antigen loading of monocyte-derived dendritic cells. (2005) (20)
Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma (2019) (20)
Generation of CD8+ T cells expressing two additional T-cell receptors (TETARs) for personalised melanoma therapy (2015) (20)
Personalized cancer immunotherapy using Systems Medicine approaches (2016) (20)
Dacarbacine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) as first-line treatment of patients with metastatic melanoma: Results of a prospective-randomized phase III study. (2004) (19)
Good Manufacturing Practice-Compliant Production and Lot-Release of Ex Vivo Expanded Regulatory T Cells As Basis for Treatment of Patients with Autoimmune and Inflammatory Disorders (2017) (19)
An improved method for RNA isolation and removal of melanin contamination from melanoma tissue: implications for tumor antigen detection and amplification. (2006) (19)
BP 230-and BP 180-Specific AutoAntibodies in Bullous Pemphigoid (2004) (19)
Diffuse melanosis in metastatic melanoma. Further evidence for disseminated single cell metastases in the skin. (1980) (19)
The dendritic, Thy-1-positive cell of murine epidermis: a new epidermal cell type of bone marrow origin. (1984) (18)
Isolation, enrichment, and culture of murine epidermal langerhans cells. (2001) (18)
Subsets of epidermal Langerhans cells as defined by lectin binding profiles. (1983) (18)
Necrotizing vasculitis associated with hepatitis C virus infection: successful treatment of vasculitis with interferon-alpha despite persistence of mixed cryoglobulinemia. (1995) (18)
Innate extracellular vesicles from melanoma patients suppress β-catenin in tumor cells by miRNA-34a (2019) (18)
Immunogenic and tolerogenic effects of the chimeric IL-2-diphtheria toxin cytocidal agent Ontak® on CD25+ cells (2014) (18)
Introduction: Cutaneous Dendritic Cells: Distinctive Antigen-Presenting Cells for Experimental Models and Disease States (1995) (18)
Expression of the Ly-5 alloantigenic system on epidermal cells. (1985) (17)
The syndrome of milker's nodules in burn injury: evidence for indirect viral transmission. (1982) (17)
Block Excision of Iridociliary Tumors Enables Molecular Profiling and Immune Vaccination. (2017) (17)
Model-based genotype-phenotype mapping used to investigate gene signatures of immune sensitivity and resistance in melanoma micrometastasis (2016) (17)
Retrospective interactive rigid fusion of (18)F-FDG-PET and CT. Additional diagnostic information in melanoma patients. (2006) (17)
The cyclin‐dependent kinase inhibitors p27Kip1 and p21Cip1 are not essential in T cell anergy (2003) (17)
Extracellular vesicles from mature dendritic cells (DC) differentiate monocytes into immature DC (2018) (17)
Melanoma‐associated chondroitin sulphate proteoglycan as a new target antigen for CD4+ T cells in melanoma patients (2009) (17)
MHC‐peptide‐specific antibodies reveal inefficient presentation of an HLA‐A*0201‐restricted, Melan‐A‐derived peptide after active intracellular processing (2007) (17)
Differential lectin binding to mammalian keratinocytes and melanocytes in vitro. (1982) (16)
In vitro complement binding on cytoplasmic structures in normal human skin: immunoelectronmicroscopic studies (1982) (16)
Detection and Characterization of Circulating Tumor Cells in Patients with Merkel Cell Carcinoma. (2019) (16)
The human dendritic cell marker CD83 maps to chromosome 6p23 (1999) (15)
Murine Whole-Organ Immune Cell Populations Revealed by Multi-epitope-Ligand Cartography (2013) (15)
CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia (2019) (15)
Immunotherapy of malignant melanoma – Basic principles and novel therapeutic approaches (2006) (15)
BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy (2018) (15)
Identical lectin binding patterns of human melanocytes and melanoma cells in vitro. (1983) (15)
Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination (2017) (15)
Arming T Cells with a gp100-Specific TCR and a CSPG4-Specific CAR Using Combined DNA- and RNA-Based Receptor Transfer (2019) (15)
Modulation of viability and maturation of human monocyte‐derived dendritic cells by oncolytic adenoviruses (2008) (14)
Murine epidermal Langerhans cells express significant amounts of class I major histocompatibility complex antigens. (1989) (14)
Checkpoint inhibitor-induced eosinophilic fasciitis following high eosinophilia associated with complete response. (2019) (14)
Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab (2017) (14)
The tanning habits and interest in sunscreen of Google users: what happened in 12 years? (2017) (14)
Human T cells expressing two additional receptors (TETARs) specific for HIV-1 recognize both epitopes. (2011) (14)
CM-CSF (granulocyte-macrophage colony stimulating factor) promotes the maturation of epidermal langeriians cells into potent immunostimulatory dendritic cells in vitro (1988) (14)
Interaction of cutaneous lymphoma cells with reactive T cells and dendritic cells: implications for dendritic cell‐based immunotherapy (2003) (13)
[Therapeutic application of TNF-alpha inhibitors infliximab and etanercept in inflammatory skin disorders]. (2003) (13)
Inhibition of CD 83 Cell Surface Expression during Dendritic Cell Maturation by Interference with Nuclear Export of CD 83 mRNA (2000) (13)
Coated Langerhans cell granules in histiocytosis X cells. (1983) (13)
NF-κB activation triggers NK-cell stimulation by monocyte-derived dendritic cells (2019) (12)
CD8+ T-cell priming and boosting: more antigen-presenting DC, or more antigen per DC? (2013) (12)
Automated closed-system manufacturing of human monocyte-derived dendritic cells for cancer immunotherapy. (2018) (12)
Pathogenetic Implications of BRAF Mutation Distribution in Stage IV Melanoma Patients (2015) (12)
Human dendritic cells efficiently phagocytose adenoviral oncolysate but require additional stimulation to mature (2012) (12)
Infliximab in a patient with refractory mucosal aphthosis (2007) (12)
STREAM: A randomized discontinuation, blinded, placebo-controlled phase II study of sorafenib (S) treatment of chemonaïve patients (pts) with metastatic uveal melanoma (MUM). (2017) (12)
Generation of HIV-1-specific T cells by electroporation of T-cell receptor RNA (2008) (12)
Enhancing lentiviral transduction to generate melanoma-specific human T cells for cancer immunotherapy. (2019) (12)
Selective accumulation of lipid within melanocytes during photochemotherapy (PUVA) of psoriasis (1982) (12)
Mycosis fungoides palmaris et plantaris--an unusual variant of cutaneous T-cell lymphoma. (2006) (12)
The Modular Nature of Dendritic Cell Responses to Commensal and Pathogenic Fungi (2012) (11)
Viral vectors for dendritic cell-based immunotherapy. (2001) (10)
[Rosacea fulminans, pyostomatitis and pyovulvitis in Crohn's disease: dapsone as key factor in combination therapy]. (2006) (10)
Interleukin-3Ralpha+ myeloid dendritic cells and mast cells develop simultaneously from different bone marrow precursors in cultures with interleukin-3. (2003) (10)
[Ulcerative stomatitis as clinical clue to inadvertent methotrexate overdose]. (1999) (10)
A micro-culture system for cloning human T lymphocytes in agar. (1981) (10)
In vitro complement-binding on cytoplasmic structures in normal human skin: I. Immunofluorescence studies. (1982) (10)
Automated Good Manufacturing Practice-compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-fiber bioreactor system overcomes a major hurdle in the manufacture of dendritic cells for cancer vaccines. (2019) (9)
Just One Position-Independent Lysine Residue Can Direct MelanA into Proteasomal Degradation following N-Terminal Fusion of Ubiquitin (2013) (9)
Life-Threatening Atypical Case of Acute Generalized Exanthematous Pustulosis (2017) (9)
Concealed complete response in melanoma patients under therapy with immune checkpoint inhibitors: two case reports (2018) (9)
Action profiles of predictors of death and survival time in stage I malignant melanoma. (1996) (9)
IMMUNOLOGIC PROPERTIES OF PURIFIED EPIDERMAL LANGERHANS CELLS (2003) (9)
[Simultaneous onset of pemphigoid and factor VIII antibody hemophilia]. (2002) (9)
Dendritic cells as immunogens for human CTL responses. (1997) (9)
Immunodeficiency and skin (1989) (9)
[Epidermolysis bullosa acquisita: diagnosis by optic immunofluorescent demonstration of junctional antigens and vitamin E treatment]. (1982) (9)
Differences of cell surface label distribution and redistribution patterns between mammalian keratinocytes and melanocytes in culture. (1981) (9)
The CD 4 + T-Cell Response of Melanoma Patients to a MAGE-A 3 Peptide Vaccine Involves Potential Regulatory T Cells (2009) (9)
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein (2017) (9)
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf Kinase inhibitory protein. (2017) (8)
Erosive pustular dermatosis of the leg in a patient with ankylosing spondylitis: neutrophilic dysfunction as a common etiological factor? (2009) (8)
Combined multi-gene analysis at the RNA and protein levels in single FFPE tissue sections. (2013) (8)
Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis (2022) (8)
Treatment of generalised vitiligo with tacrolimus 0.1% ointment vs. UVB intense pulsed light phototherapy: a pilot study. (2014) (8)
Characterization of tanning behavior assessed via online survey: Attitudes, habits, and preventive measures with focus on sunscreen use (2019) (8)
[Bullous autoimmune dermatoses. 3: Diagnosis and therapy]. (2002) (7)
Testing a new staging system for cutaneous melanoma proposed by the American Joint Committee on Cancer. (2002) (7)
[Bullous autoimmune dermatoses. 2: Pathogenesis]. (2002) (7)
Electroporated Antigen-Encoding mRNA Is Not a Danger Signal to Human Mature Monocyte-Derived Dendritic Cells (2015) (7)
TNF alpha interrupts antigen-presenting function of Langerhans cells by two mechanisms: loss of immunogenic peptides and impairment of antigen-independent T cell clustering. (1995) (7)
Successful Treatment of Pyoderma Gangrenosum with Intravenous Immunoglobulins during Pregnancy (2012) (7)
Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells. (2017) (7)
Fluorescein-guided confocal laser endomicroscopy for the detection of ipilimumab-induced colitis (2012) (6)
Malignant transformation of a chronic leg ulcer (2009) (6)
Risk Factors for Regional and Systemic Metastases in Patients with Sentinel Lymph Node-negative Melanoma (2018) (6)
In vitro complement binding in human skin cells with altered differentiation. (1983) (6)
Cytokine Receptors on Epidermal Langerhans Cells (1995) (6)
Differential clinical response to alefacept in combination with methotrexate in two patients with refractory palmar psoriasis (2007) (6)
[Malignant melanoma. Diagnosis and therapy]. (2005) (6)
Sarcoidosis Under Dendritic Cell Vaccination Immunotherapy in Long-term Responding Patients with Metastatic Melanoma. (2017) (6)
Epidermal Langerhans cells in myelodysplastic syndromes are abnormal. (1990) (6)
Interest in tanning beds and sunscreen in German‐speaking countries (2017) (6)
Dendritic cells: indispensable? (2011) (6)
Blood Eosinophilia Is an on-Treatment Biomarker in Patients with Solid Tumors Undergoing Dendritic Cell Vaccination with Autologous Tumor-RNA (2020) (5)
A new method to monitor antigen-specific CD8+ T cells, avoiding additional target cells and the restriction to human leukocyte antigen haplotype (2015) (5)
15 – The Immunologic Properties of Epidermal Langerhans Cells (1988) (5)
BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation (2021) (5)
Epidermal Langerhans Cells as a Model for Studying the Effects of Granulocyte-Macrophage Colony-Stimulating Factor and Other Cytokines on the Biology of Dendritic Cells (1993) (5)
Factors Influencing Disease Progression in Patients with Head and Neck Melanoma. (2017) (5)
Safety and tolerability of a single infusion of autologous ex vivo expanded regulatory T cells in adults with ulcerative colitis (ER-TREG 01): protocol of a phase 1, open-label, fast-track dose-escalation clinical trial (2021) (5)
GM-CSF — A Granulocyte/Macrophage/Dendritic Cell Stimulating Factor1 (1993) (5)
Predictable clinical responses to sorafenib in stage IV uveal melanoma. (2012) (5)
Histiocytosis-X in gynecology. (1983) (5)
The Role and Mechanism of Action of Dendritic Cells in Transplantation Immunity (1986) (4)
Corrigendum to “Efficient elutriation of monocytes within a closed system (Elutra™) for clinical-scale generation of dendritic cells” [Journal of Immunological Methods 298 (2005) 61–72] (2005) (4)
Herpesvirus Infections in the Immunocompromised Host (1989) (4)
Abnormal expansions of granular lymphocytes: Reactive lymphocytosis or chronic leukemia? case report and literature review (1986) (4)
Cancer Therapy : Clinical Frequency of Circulating Tregs with Demethylated FOXP 3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents (2011) (4)
Dendritic cell-based vaccination against cancer (2003) (4)
Purification and Characterization of Epidermal Langerhans Cells (1987) (4)
Remembering Ralph Steinman (2011) (4)
Merkel Cell Carcinoma of the Head and Neck Compared to Other Anatomical Sites in a Real-World Setting: Importance of Surgical Therapy for Facial Tumors (2019) (4)
Plasma-derived extracellular vesicles discriminate type-1 allergy subjects from non-allergic controls (2021) (4)
Dendritic cell vaccination in metastatic uveal melanoma as compassionate treatment: Immunological and clinical responses. (2019) (3)
Garbe C, Hauschild A, Volkenandt M et al.Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Melanoma Res 17:393-399 (2008) (3)
Correction: Inhibition of the Transcription Factor Foxp3 Converts Desmoglein 3-Specific Type 1 Regulatory T Cells into Th2-Like Cells (2012) (3)
[Bleomycin-induced linear hyperpigmentation]. (1984) (3)
[Refractory cutaneous necrotizing vasculitis. Successful sulfone therapy]. (2006) (2)
Erratum (2010) (2)
[Unusual variants of blue naevi--a report of four cases (author's transl)]. (1979) (2)
NRAS-mutated melanoma patients have similar response rates to therapy with checkpoint inhibitors as other cohorts. (2017) (2)
Curatopes Melanoma: a database of predicted T cell epitopes from overly expressed proteins in metastatic cutaneous melanoma. (2019) (2)
Additional file 8 (2012) (2)
Is Up-Regulated by IL-1 Dendritic Cells + Expressed on Mature CD 83 Signaling Lymphocytic Activation Molecule Is (2001) (2)
Treatment of vitiligo using targeted UVB-Intense Pulsed Light (IPL)- phototherapy: Evaluation of variables affecting therapeutic success (2014) (2)
[Phlebology in German departments of dermatology. An analysis on behalf of the German Society of Phlebology]. (2013) (2)
Can checkpoint inhibitor therapy improve response to chemotherapy (2017) (2)
A simple method to grow large numbers of dendritic cells from human peripheral blood (1994) (2)
A Chimeric IL-15/IL-15Rα Molecule Expressed on NFκB-Activated Dendritic Cells Supports Their Capability to Activate Natural Killer Cells (2021) (2)
Cryopreservation impairs cytotoxicity and migration of NK cells in 3-D tissue: Implications for cancer immunotherapy (2019) (2)
Dendritic cells are a source of interleukin-12 (1994) (2)
CFU-gm assay, cytochemical and electron microscopic studies in agar in patients with preleukemic syndrome and aplastic anemia. (1985) (2)
Most Cited Authors... (2008) (2)
Kurzleitlinie: Malignes Melanom der Haut (2006) (2)
Regulatory , Contact-dependent T Cells Induce Interleukin 1 0 – producing , Contact-independent Type 1-like Regulatory T Cells (2002) (2)
Predicting the response to anti-PD1 therapy in metastatic melanoma (2016) (2)
Antigen processing capacity of dendritic cells from mice of different MHC backgrounds: down-regulation upon culture and evidence for heterogeneity of dendritic cell populations. (1995) (2)
[EPICO in the treatment of small cell bronchial cancer. 3. Intermediate analysis]. (1986) (2)
Maturation-resistant immature dendritic cells generated with low doses of GM-CSF prolong heart allograft survival in vivo (2000) (2)
Peptide Dendritic Cells Pulsed with a MAGE-3 . A 1 Melanoma Patients Vaccinated with Polyclonal CTL Responses Observed in (2003) (2)
Envisioning the Application of Systems Biology in Cancer Immunology (2020) (2)
Long-term efficacy and safety of TNF-alpha-inhibitor infliximab in severe atopic dermatitis1 (2004) (2)
The IL-2 Diphtheria Toxin Fusion Protein Denileukin Diftitox Modulates the Onset of Diabetes in Female Nonobese Diabetic Animals in a Time-Dependent Manner and Breaks Tolerance in Male Nonobese Diabetic Animals (2012) (1)
Introduction to The Renaissance of Cancer Immunotherapy (2013) (1)
The price of tumor control (2013) (1)
173 γ/δ T cells RNA-transfected with a T-cell receptor and a chimeric antigen receptor specific for melanoma (2016) (1)
A novel cell population within mouse epidermis (1984) (1)
[Bullous autoimmune dermatoses. 1: Classification]. (2002) (1)
Assessment of sorafenib induced changes in tumor perfusion of uveal melanoma metastases with dynamic contrast-enhanced ultrasound (DCE-US) (2021) (1)
Distribution of anionic surface sites on human melanocytes and human melanoma cells in culture (2004) (1)
Guess what! Tinea and erysipelas carcinomatosum. (2001) (1)
Dendritic cell vaccination in melanoma (2010) (1)
A severe outbreak of Aujeszky's disease associated with influenza virus in pigs. (1960) (1)
Use of monocyte-derived dendritic cells in cancer immunotherapy (2003) (1)
Monitoring skin metastases during immuno‐ and targeted therapy using total‐body 3D photography (2020) (1)
Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction? (2014) (1)
Affinity-Dependent Cytolytic Activity Human CTLs Mediate Antibody TCR-Like Human Antibodies Expressed on (2002) (1)
Analysis of dendritic cells in human lymphoid organs (2012) (1)
Advances in cellular therapy: 5th International Symposium on the clinical use of cellular products, 19 and 20 March 2009, Nürnberg, Germany (2010) (1)
Herpesvirus infections in the immunocompromised host. Clinical spectrum, diagnosis, management and prophylaxis. (1989) (1)
Can checkpoint inhibitor therapy improve response to chemotherapy? (2017) (1)
[Cholesterol emboli during coumarin therapy]. (2003) (1)
An integrative computational framework for personalized detection of tumor epitopes in melanoma immunotherapy (2016) (1)
Dust‐ and rod‐like particles in cutaneous biopsies of patients with systemic lupus erythematosus (1989) (1)
Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma (2018) (1)
Inhalt, Vol. 9, Supplement 1, 1986 (2004) (0)
Identification of Proliferating Dendritic Cell (2003) (0)
Abstracts from the 4th ImmunoTherapy of Cancer Conference (2017) (0)
Contents, Vol. 22, Supplement 1, 1982 (1982) (0)
Immunotherapy of Malignant Melanoma (2014) (0)
[Livid-colored tumor on the scalp]. (2005) (0)
[Chronic fistulas with impaired wound healing]. (2006) (0)
DEC-205 targeting of dendritic cells: a challenging approach of antigen loading (2011) (0)
P770 Autologous regulatory T cell transfer in patients with refractory ulcerative colitis: Interim report of a phase 1, dose-escalation trial (2023) (0)
Monocyte-derived dendritic cells to induce immunity to cancer (2001) (0)
Method and composition for the production of mature dendritic cells (1998) (0)
Disappearance of Certain Acidic Organelles (2003) (0)
Pemphigus Vulgaris in Healthy Individuals than in Patients with Desmoglein 3 Are More Frequently Detected Type I Regulatory T Cells Specific for (2004) (0)
Stem cell markers of the human hair follicle- characterization of a tissue engineered reconstruct based on plucked hairs compared to human scalp. (2007) (0)
Proliferating Dendritic Cell Progenitors in H u m a n Blood (2003) (0)
Comprehensive characterization of plasma extracellular vesicle microRNAs in melanoma patients (2016) (0)
[Psoriasiform exanthem in a patient with MEN-I]. (2008) (0)
Optimizing the antigen loading of dendritic cells with exogenous peptides (2004) (0)
Deficient for TNF Receptor-1 Continuous Proliferation of Dendritic Cells Cutting Edge: Resistance to Apoptosis and (2000) (0)
Comparing immunogenicities of tumor-specific antigens administered as therapeutic vaccines in metastatic melanoma patients (2007) (0)
Book Review / Announcements (1995) (0)
BP230Clustered in Distinct Regions of BP180 and Epitopes Pemphigoid (BP) Patients Recognize Autoreactive T and B Cells from Bullous (2006) (0)
Identification of a melanoma-associated chondroitin sulfate proteoglycan (MCSP) peptide recognized by CD4+ T lymphocytes on human melanoma cells (2004) (0)
[Recurrent angioedema with gastroenteritis in blood and tissue eosinophilia]. (1998) (0)
[Annular erythema associated wih pruritus in a 69-year-old female]. (2005) (0)
Efficient transduction of mature human dendritic cells by using an avian influenza virus as a vector (1998) (0)
Contents Vol. 204, 2002 (2002) (0)
Abstract B030: Predicting the response of uveal melanoma to immunotherapy with MRI assessments (2019) (0)
The galectin disaccharide ligand LacNAc prevents loss of tetramer staining after T cell activation (2009) (0)
Impressum, Vol. 9, Supplement 1, 1986 (1986) (0)
Ex vivo generation of large numbers of mature dendritic cells from leukapheresis products for immunotherapy of cancer (1998) (0)
Subject Index Vol. 204, 2002 (2002) (0)
Kutane CD 56 positive NK-Zell-Lymphome (2003) (0)
Association of PD-L1 expression in melanoma with response and prognosis to ipilimumab. (2015) (0)
manipulated dendritic cells in its path signal transmission NFkB (2011) (0)
Cutaneous Biology Interaction of cutaneous lymphoma cells with reactive T cells and dendritic cells: implications for dendritic cell-based immunotherapy (2003) (0)
TNF-Matured Dendritic II / Self-Peptide and CD 1 d / Self-Glycolipid Interdependency of MHC Class (2007) (0)
T Cells Resulting in a Failure to Lyse Tumor Cells + Specific Anergy in CD8 - Treated Human Dendritic Cells Induce a Melanoma-Antigen - Interleukin-10 (2012) (0)
Cells for Protection from Autoimmunity Presentation by TNF-Matured Dendritic II/Self-Peptide and CD1d/Self-Glycolipid Interdependency of MHC Class (2007) (0)
The tanning habits and interest in sunscreen of Google Users: What happened in twelve years? (2017) (0)
MHC-peptide specific antibodies reveal inefficient presentation of an antigenic Melan-A derived peptide after active intracellular processing (2006) (0)
A method for in vitro cultivation of dendritic precursor cells and their use for making immunogenic (1993) (0)
[Ulceration of the hard palate in a 50-year-old patient]. (2007) (0)
501 A web-based comprehensive map including regulatory pathways subverted in melanoma that can be visualized, browsed and used for analysing cell line and patient high through put data (2016) (0)
Kutane Lymphome (2013) (0)
GMP-compliant human monocyte-derived dendritic cells for cancer vaccination generated by using the Quantum® hollow fiber bioreactor system (2019) (0)
[Immunization strategies for treating melanoma]. (2008) (0)
GM-CSF IL-12 Production and Their Dependency on I and II for Dendritic Cell Maturation and Differential Functions of IL-4 Receptor Types (2002) (0)
Formation and kinetics of MHC class I-ovalbumin peptide complexes on murine dendritic cells following an ovalbumin peptide-pulse (1998) (0)
Randomized, open-label phase III study to evaluate the adjuvant vaccination with tumor RNAloaded autologous dendritic cells versus observation of patients with resected monosomy 3 uveal melanoma (2016) (0)
PP-028-35 Local LIGHT regulates inflamed draining lymph node hypertrophy (2010) (0)
Autoimmunity and Healthy Individuals in the Absence of Sulphate Proteoglycan in Melanoma Patients the Melanoma-Associated Chondroitin T Cell Responses to + Tumor-Reactive CD 4 (2007) (0)
1007. Genetic Strategies to Improve Oncolytic Adenoviruses for Targeted and Efficient Virotherapy of Malignant Melanoma (2005) (0)
RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma (2017) (0)
A molecular strategy to identify molecules that are specific for dendritic cells and/or critical to their unique immunostimulatory function. (1995) (0)
Contents, Vol. 112, 1997 (1997) (0)
Analysis of dendritic cells in human lymphoid organs (2012) (0)
RETRACTION of: Optimizing the exogenous antigen loading of monocyte-derived dendritic cells. (2012) (0)
Tinea and Erysipelas carcinomatosum (2001) (0)
Transient response to nivolumab and relapse after infliximab in a patient with primary cutaneous CD8‐positive aggressive epidermotropic cytotoxic T‐cell lymphoma (2020) (0)
Title Page / Contents / Foreword (1989) (0)
cell activity in various disease states Human large granular lymphocytes and their relationship to natural killer (2011) (0)
Cultured Human Dendritic Cells (1996) (0)
An improved method for generating large quantities of dendritic cells from mouse bone marrow and novel factors regulating their maturation (1998) (0)
Present status of eczema and its treatment (1994) (0)
510 SPPL3-mediated ADAM10 Activation is a Key Step in the evolution of BRAFV600E+ Superficial Spreading Melanomas (SSM) (2016) (0)
An Integrative Computational Pipeline for Detection of Tumor Epitopes in Cancer Patients (2016) (0)
Correction: MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing (2008) (0)
Chemotaxis in immunity (WS-029) Chairpersons: Osamu Yoshie, Naofumi Mukaida (2010) (0)
Clinical responses observed in patients treated with BRAF inhibitors do not support the suggestion of intra-patient BRAF heterogeneity as all metastases have a uniform initial metabolic response to BRAF inhibition assessed using FDG-PET imaging (McArthur (2014) (0)
Correction: Type I Regulatory T Cells Specific for Desmoglein 3 Are More Frequently Detected in Healthy Individuals than in Patients with Pemphigus Vulgaris (2012) (0)
Broad T cell reactivity against a tumour-associated self antigen in melanoma patients and healthy individuals without obvious signs of autoimmunity (2007) (0)
[Bone marrow culture, cytochemistry and electron microscopy in agar in patients with preleukemic syndrome and aplastic anemia]. (1982) (0)
A One-Armed Phase I Dose Escalation Trial Design: Personalized Vaccination with IKKβ-Matured, RNA-Loaded Dendritic Cells for Metastatic Uveal Melanoma (2022) (0)
[Multiple atypical milker's nodes in scalded areas]. (1982) (0)
Subject Index, Vol. 112, 1997 (1997) (0)
177 Combining a CAR and a TCR to generate T cells expressing two additional receptors (TETARs) for melanoma immunotherapy (2016) (0)
AllelesCarriers of PV-Associated HLA Class II Pemphigus Vulgaris (PV) and Healthy Responses to Desmoglein 3 in Patients with Dichotomy of Autoreactive Th1 and Th2 Cell (2002) (0)
Radioimmunoassay of urinary 5-hydroxy-3-indoleacetic acid (5-HIAA) (1986) (0)
dendritic cells and stimulates survival of resting T Denileukin diftitox ( ONTAK ) induces a tolerogenic phenotype in (2013) (0)
Human and Murine Skin Cells and Dermal Dendritic Cells from Necessary for the Migration of Langerhans Matrix Metalloproteinases 9 and 2 Are (2002) (0)
Epidermal Langerhans cells in cell-mediated immunity (1992) (0)
Alleles Carriers of PV-Associated HLA Class II Pemphigus Vulgaris ( PV ) and Healthy Responses to Desmoglein 3 in Patients with Dichotomy of Autoreactive Th 1 and Th 2 Cell (2002) (0)
IMMUNOLOGIC PROPERTIES OF PURIFIED EPIDERMAL (1986) (0)
215 Ex vivo expanded NK cells up-regulate natural cytotoxicity receptors able to mediate autologous melanoma cell killing (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gerold Schuler?

Gerold Schuler is affiliated with the following schools:

Gerold Schuler's Academic­Influence.com Rankings

Gerold Schuler's Degrees

Similar Degrees You Can Earn

Why Is Gerold Schuler Influential?

Gerold Schuler's Published Works

Published Works

What Schools Are Affiliated With Gerold Schuler?

Gerold Schuler's AcademicInfluence.com Rankings